Zhaoming Lu

508 total citations
19 papers, 440 citations indexed

About

Zhaoming Lu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Zhaoming Lu has authored 19 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Zhaoming Lu's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer-related gene regulation (7 papers) and Kruppel-like factors research (5 papers). Zhaoming Lu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer-related gene regulation (7 papers) and Kruppel-like factors research (5 papers). Zhaoming Lu collaborates with scholars based in China and New Zealand. Zhaoming Lu's co-authors include Guiqin Hou, Lexun Xue, Tianli Fan, Fang Tian, Yandan Ren, Wen Zhao, Hong‐Min Liu, Hongtao Liu, Peirong Xu and Bin Yu and has published in prestigious journals such as Biochemical Pharmacology, Cancer Letters and Biomedicine & Pharmacotherapy.

In The Last Decade

Zhaoming Lu

19 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaoming Lu China 12 311 93 71 63 45 19 440
Dong Guo China 12 294 0.9× 105 1.1× 58 0.8× 30 0.5× 54 1.2× 31 458
Gang Bao China 13 295 0.9× 103 1.1× 95 1.3× 31 0.5× 23 0.5× 23 456
Dongmei Guo China 13 276 0.9× 106 1.1× 77 1.1× 33 0.5× 27 0.6× 35 409
Imade Aït-Arsa France 11 205 0.7× 73 0.8× 153 2.2× 34 0.5× 47 1.0× 14 440
Hua Gu China 13 216 0.7× 57 0.6× 115 1.6× 54 0.9× 48 1.1× 32 487
Chong Zeng China 15 387 1.2× 173 1.9× 53 0.7× 136 2.2× 54 1.2× 34 560
Seung Baek Lee South Korea 8 420 1.4× 107 1.2× 85 1.2× 48 0.8× 112 2.5× 9 576
Zhenlian Wang China 12 378 1.2× 108 1.2× 111 1.6× 18 0.3× 48 1.1× 19 615

Countries citing papers authored by Zhaoming Lu

Since Specialization
Citations

This map shows the geographic impact of Zhaoming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoming Lu more than expected).

Fields of papers citing papers by Zhaoming Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoming Lu. The network helps show where Zhaoming Lu may publish in the future.

Co-authorship network of co-authors of Zhaoming Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoming Lu. A scholar is included among the top collaborators of Zhaoming Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoming Lu. Zhaoming Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lu, Zhaoming, Yalin Zhang, Yujia Xu, et al.. (2021). mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma. Molecular Biology Reports. 49(1). 451–461. 6 indexed citations
2.
Yang, Li, Yu Zhao, Wuduo Zhao, et al.. (2020). OP16 induces deadly autophagy and apoptosis of cells by inhibiting Akt in esophageal squamous cell carcinoma. Molecular and Cellular Biochemistry. 472(1-2). 219–230. 7 indexed citations
3.
Lu, Zhaoming, Yandan Ren, Li Yang, et al.. (2020). Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinoma. Acta Pharmaceutica Sinica B. 11(5). 1246–1260. 40 indexed citations
4.
Lu, Zhaoming, Xiaojing Shi, Fanghua Gong, et al.. (2020). RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma. Acta Pharmaceutica Sinica B. 10(6). 1004–1019. 23 indexed citations
5.
Zhang, Mengying, Yi Hu, Yu Zhao, et al.. (2020). miR-199a-3p suppresses progression of esophageal squamous cell carcinoma through inhibiting mTOR/p70S6K pathway. Anti-Cancer Drugs. 32(2). 157–167. 6 indexed citations
6.
Hou, Guiqin, Yi‐Ru Bai, Yandan Ren, et al.. (2020). Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin. Canadian Journal of Physiology and Pharmacology. 98(7). 449–458. 16 indexed citations
7.
Hou, Guiqin, Qi Zhao, Mengying Zhang, et al.. (2019). <p>LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma</p>. OncoTargets and Therapy. Volume 12. 5215–5225. 16 indexed citations
8.
Hou, Guiqin, Qi Zhao, Mingjie Zhang, et al.. (2018). Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy. 106. 1348–1356. 29 indexed citations
9.
Lu, Zhaoming, Yandan Ren, Mengying Zhang, et al.. (2018). FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells. Biomedicine & Pharmacotherapy. 107. 1370–1376. 23 indexed citations
10.
11.
Lu, Zhaoming, et al.. (2016). Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma. Journal of Immunology Research. 2016. 1–9. 10 indexed citations
12.
13.
Lu, Zhaoming, et al.. (2015). Low-frequency repetitive transcranial magnetic stimulation on Parkinson motor function: a meta-analysis of randomised controlled trials. Acta Neuropsychiatrica. 27(2). 82–89. 34 indexed citations
14.
Hou, Guiqin, Shuai Yang, Yuanyuan Zhou, et al.. (2014). Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin. Journal of Immunology Research. 2014. 1–9. 23 indexed citations
15.
Hou, Guiqin, Zhaoming Lu, Mingyue Liu, Hong‐Min Liu, & Lexun Xue. (2010). Mutational Analysis of the PTEN Gene and Its Effects in Esophageal Squamous Cell Carcinoma. Digestive Diseases and Sciences. 56(5). 1315–1322. 11 indexed citations
16.
17.
Lu, Zhaoming. (2007). Notch1 mRNA and protein expression in human esophageal squamous cell carcinoma and normal esophageal tissues. 3 indexed citations
18.
Lu, Zhaoming, et al.. (2007). [Expression of Notch1 gene in esophageal squamous cell carcinoma cell line EC9706 and its effect on cell apoptosis].. PubMed. 26(10). 1074–9. 1 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong Guo Breakdown of academic impact, for papers by Gang Bao Breakdown of academic impact, for papers by Dongmei Guo Breakdown of academic impact, for papers by Imade Aït-Arsa Breakdown of academic impact, for papers by Hua Gu Breakdown of academic impact, for papers by Chong Zeng Breakdown of academic impact, for papers by Seung Baek Lee Breakdown of academic impact, for papers by Zhenlian Wang
Rankless by CCL
2026